This Web Site is committed to the memory of Janis Morrow.

Human liver   

INDEX :HCV BLOOD TESTS/Labs


 

Page One:


Great Place to look up your test results :

 Liver Function Tests


Liver function tests: defining what's normal


A breakdown of what an LFT (Liver Function Test) may include, what it does, normal values, and what other than normal values can mean. Also drugs and other things that can affect the results of each test


Page Two:


Overall view Of Liver Function Tests ( Long and Short Versions)
 

Page Three:


All  Tests In Liver Disease

Upper Endoscopy
ERCP (Endoscopic Retrograde Cholangiopancreatography)

Sclerotherapy for esophageal varices (also called endoscopic sclerotherapy)

Esophageal Varices
Lower GI Series
Colonoscopy
Upper GI Series
MRI Scan
CT Scan
Ultrasound
 

 


Page Four:


Hepatitis C Test Results

Testing and Diagnosis
What does it all mean? (Interpreting Liver function tests)

 


Page Five:


Functions of the blood

Formation of Blood Cells ,Red Blood Cells ,Oxygen Transport Carbon Dioxide Transport , Anemia , Blood Groups ,White Blood Cells , Lymphocytes , Monocytes , Neutrophils Eosinophils , Basophils Platelets, Plasma , Serum , Proteins Serum ,Lipids


On This Page:


Know Your ALT

ALT Predicts Mortality & General Health -

Understanding Log Changes in your Viral Load

( What is a 2 log Increase or Decrease ?


      

Understanding Log Changes in your Viral Load

( What is a 2 log Increase or Decrease ?)

An easy way to figure out log changes is to either drop the last "0"or add "0"to the original number. Drop one "0" for one log drop and two "00" for a two log drop.

Changes in viral load are often reported as logarithmic or "log changes." This mathematical term denotes a change in the value of what is being measured by a factor of 10. For example, if the baseline viral load by PCR were 20,000 copies/ml plasma, then a 1 log increase equals a 10-fold (10 times) increase or 200,000 copies/ml plasma.  A 2 log increase equals 2,000,000 copies/ml plasma, or a 100-fold increase.

Using the same starting point of 20,000 copies/ml plasma, a 1 log decrease means that the viral load has dropped to 2,000 copies/ml. A 2 log decrease equals a viral load of 200 copies/ml plasma.

An easy way to figure out log changes is to either drop the last "0"or add "0"to the original number.

      Any change of less than one-half log is considered insignificant. More simply, if the viral load measurement has not tripled or dropped to one-third of its previous level, the difference might be unimportant. For example, if the baseline viral load were 20,000 copies, a rise to 60,000 or a fall to 7,000 copies might just be the result of transient changes.  Repeat testing of a single specimen may give two quite different results and natural biological day-to-day variability of samples from the same person may cause measurements to vary slightly. Researchers believe that clinical decisions made on the basis of changes in viral load ideally should be based on measurements taken 2-3 weeks apart.
http://vhaaidsinfo.cio.med.va.gov/aidsinfo/newsletters/phe/phe6.htm

 

Know Your ALT 

The Serum Alt: Frequently Asked Questions

What is it?

The ALT is a protein manufactured in the liver which participates in metabolism.  The term ALT refers to alanine-amino transferase. This protein is an enzyme which participates in modifying aminoacids, the building blocks of proteins. The ALT is made predominately in the liver and therefore alterations in the serum ALT can be directly related to disturbances of liver structure and function.

Is the serum ALT hard to measure?

It is straightforward to have ones blood sample tested for a serum ALT, it only requires obtaining a blood sample. The serum ALT is easily measured in laboratories throughout the world. The methodology may vary from laboratory to laboratory, making direct comparisons of the absolute serum ALT value difficult, but all laboratories have a normal range for men and women. 

What does an elevated serum ALT reflect?

The ALT is manufactured within liver cells. Elevations in the serum ALT reflect alterations in the structure and function of the liver.  Damaged liver cells release ALT into the blood stream where it can then be measured. The serum ALT, therefore, reflects damage to liver cells, liver injury, and underlying liver disease.

Why should I know my serum ALT?

We should all be aware of our health. Unfortunately, unlike diseases affecting other organs, injury to the liver can be silent. Patients may not have any symptoms and the ALT can be elevated for years before one is aware of an underlying liver disease. When one develops symptoms from liver disease, it usually reflects advanced damage to the liver. Once significant damage to the liver has occurred, therapies other than liver transplantation, may not be very beneficial. Therefore, making the diagnosis of a liver disease early in its course can be very beneficial in regards to receiving specific therapies and modifying lifestyle.

My doctor also measures other blood tests. What are they and is the serum ALT the best test?

The liver is a complex organ with a variety of essential functions for the body. It participates in metabolism, produces bile, and generates proteins secreted into the blood, so your doctor may measure compounds associated with all of these liver functions. All of those tests are frequently measured in a battery of tests referred to as a “liver panel.” Depending upon the type and nature of the underlying liver injury and therefore the liver disease, changes in the magnitude of the various components of this panel provide meaningful information to your physician. However, if one simply wants to know whether one has liver wellness or may have an underlying liver disease, the ALT is likely the most sensitive test for the vast majority of liver illness.

Is there a direct correlation between the magnitude of the serum ALT elevation and the severity of the underlying liver disease?

Although there can be a relationship between the magnitude of elevation in the serum ALT and the severity of the abnormalities in liver structure and function, this relationship is not absolute. Patients with advanced scarring of the liver may have significant liver dysfunction despite only mild elevations of the serum ALT. Therefore, any elevation of the serum ALT should be taken seriously and one should seek appropriate medical care to determine the cause.

What are some common causes of an elevated serum ALT?

Perhaps the most common cause in the North American population is fat accumulation within liver cells. Fat can accumulate anywhere in the body, but its accumulation in the liver cells is toxic to the liver. In particular, patients who are above their ideal body weight, have diabetes, or elevations in their blood lipids, may be at risk for having fat within the liver. The serum ALT is a common approach to determine whether one may have fat in the liver and if it is injurious to this organ. Other common causes of an elevated serum ALT include excessive consumption of alcohol, infection by chronic hepatitis viruses such as hepatitis B and C, toxicity from pharmaceutical medications, a genetic liver disease associated with an excess accumulation of iron in the liver, and autoimmune liver diseases.  The latter are a variety of liver diseases in which the body’s immune system inflicts damage on ones own organ.

I have an elevated ALT. What should I do?

If you have an elevated ALT, you should seek medical attention. The vast majority of primary care physicians and specialists in gastroenterology and hepatology, can perform the necessary testing to determine the cause of an elevated serum ALT.

How often should I have my serum ALT measured?

Like the serum cholesterol and blood glucose tests for elevated cholesterol and diabetes, respectively; one should have the serum ALT measured repeatedly and regularly over time. A conservative approach would be to have ones serum ALT measured on an annual basis during the annual physical examination

Elevated ALT and AST Predict Higher Mortality in General Population

By Liz Highleyman

Elevated levels of the liver enzymes alanine and aspartate aminotransferase (ALT and AST) are associated with a greater 10-year risk of death in the general population, regardless of presence of viral hepatitis or other known liver disease, according to a study presented last month at the American Association for the Study of Liver Diseases (AASLD) annual meeting in Boston.

Researchers from the Mayo Clinic in Rochester, MN, analyzed data from all community residents who had their ALT or AST measured during 1995. Subjects were followed forward and their survival was determined. In order to exclude patients with abnormal liver function tests due to pre-existing terminal illness, deaths within the first 2 years were excluded.

Results

A total of 6792 subjects had ALT measured at least once, of whom 5885 had levels less than the upper limit of normal (ULN) and 907 had abnormal results.

AST was measured at least once in 18,330 individuals, of whom 15,991 had normal levels and 2339 had abnormal levels.

Over 10 years, there was a nearly linear relationship between aminotransferase levels and standardized mortality risk.

Subjects with normal AST or ALT had lower-than-expected mortality rates.

The risk of death among subjects with normal ALT was 0.61, compared with 1.22 for those with elevated levels (P < 0.22) and 1.63 for those with levels > 2 x ULN (P < 0.01).

For subjects with normal AST, the mortality rate was 0.95, compared with 1.33 for those with elevated AST (P < 0.01) and 1.79 for those with levels > 2 x ULN (P < 0.01).

Conclusion

"Serum levels of AST and ALT are predictive of future mortality in community populations," the researchers concluded. "These data suggest that screening for abnormal AST or ALT should be considered as an important component of general medical examination."
"Know Your ALT" Campaign

At the conference, AASLD launched a public education campaign recommending that Americans pay more attention to ALT as an important marker of liver health and disease -- especially as levels of obesity rise and more people develop fatty liver disease.

The association also urged the recalibration of what is considered normal ALT to reflect levels in individuals with healthy livers. Existing so-called "normal" references ranges may be based on populations that include apparently healthy individuals with unrecognized liver disease related to the metabolic syndrome, fatty liver, use of alcohol or toxic drugs, or undiagnosed viral hepatitis.

According to AASLD, persistently elevated ALT should always be further evaluated for a cause, given that too many practitioners currently ignore minor elevations in asymptomatic individuals. Diagnosis of liver disease at early, more treatable stages is crucial, not least due to the dire shortage of donated livers for transplantation.

Further, the organization stated, "ALT is not only an indicator of liver disease but also a gauge of general health, as there is a strong relationship between ALT activity and mortality, even when the life-threatening process does not originate from the liver."

AASLD intends to promote ALT as a routine indicator of overall health, similar to cholesterol or blood pressure.

11/14/06

Reference
W Kim, J T Benson, T M Therneau, and others. Serum Aminotransferase Concentrations and Risk of Mortality in a Community Population

http://www.hivandhepatitis.com/2006icr/aasld/docs/111406_d.html


 

TWO New Tests to detect Fibrosis ;

2007

What is the best non invasive method for early prediction of cirrhosis in chronic hepatitis C? Prospective comparison between Fibroscan and serum markers (Lok index, APRI, AST/ALT ratio, platelet count and Fibrotest) -

What is the impact of higher sensitivity assay on response-guided therapy in hepatitis C virus (HCV)? Comparative analysis between COBAS TaqMan™ and COBAS Amplicor™ tests from two large, randomized, international trials of PEGASYS plus COPEGUS

Non-Invasive and Inexpensive Fibrosis Evaluation for HCV

Comparison of 6 Non-invasive Measures for Diagnosing Liver Fibrosis in Hepatitis C Patients

New Index for Assessing Liver Fibrosis  

The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in
chronic hepatitis C.

Battle of the New, Non-invasive Measures of Fibrosis: FibroScan versus FibroTest

Feb 21 2006

Noninvasive Markers of Fibrosis for Longitudinal Assessment of Fibrosis in Chronic Liver Disease: Are They Ready for Prime Time?  EDITORIAL

Sep 02 2005

 

Prometheus Laboratories Introduces Non-Invasive Test for the Detection of Liver Fibrosis FIBROSpect

 

LabCorp® Announces U.S. Launch Of Exclusive Liver Fibrosis Assay HCV Fibrosure™

Blood Tests Provide Alternative to Liver Biopsy for Assessing Status of Liver Disease in HCV Patients

 

The new COBAS TaqMan assay is a highly sensitive
A New, Sensitive, Real Time PCR-based Assay for Quantification of HCV RNA from Roche Diagnostics
Viral Load Test
Quest Diagnostics Announces Availability of HEPTIMAX Ultra-Sensitive Quantitative Hepatitis C Virus Test
Understanding Log Changes in your Viral Load
The Importance of Laboratory Test Results in Hepatitis C Infection
Third Wave Launches Invader(R) HCV Genotyping Reagents At Clinical Virology Symposium

 

 


Found on our Biopsy Pages :

Scoring and Grading Liver Biopsies

Original HAI (Histology Activity Index), the Modified HAI, and the Metavir.

 

 

 

 

 

 


copyright © 2003-2008 Janis and Friends Hepatitis C Web Site|  design )by carter

Design downloaded from Zeroweb.org: Free website templates, layouts, and tools.